![Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-07T163307.697.png)
Insights
![Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-07T163307.697.png)
Deal Insights
Actigraph, a Portfolio Company of Archimed, acquired Biofourmis Connect, a Division of Biofourmis, to Establish a Software and Data Ecosystem for Clinical Research Throughout the Drug-product Lifecycle and Across Therapeutic Areas
Learn More
![Pharma Services Blue Book November 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202024-12-30T172014.577.png)
BlueBook
Pharma Services Blue Book November 2024
Highlights from this edition: Trial Management Associates was acquired by Headlands Research, TA Associates announced its acquisition of Nexus AG, AmplifyBio closed a $50MM Series A Financing, led by Vitrian
Download Now
![Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(1).png)
Deal Insights
Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio
Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio
Learn More
![Pharma Services: Drug Supply Chain BlueBook November 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-06T120438.784.png)
BlueBook
Pharma Services: Drug Supply Chain BlueBook November 2024
Highlights from this edition: Avid Bioservices was acquired by Ampersand and GHO Capital, Patrition announced its acquisition of BGM Group, AmplifyBio closed a $50MM Series A Financing, led by Vitrian
Download Now
![Pharma Services: Pharmaceutical Commerce BlueBook November 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20-%202025-01-06T121211.560.png)
BlueBook
Pharma Services: Pharmaceutical Commerce BlueBook November 2024
Highlights from this edition: BOLDSCIENCE was acquired by Minds + Assembly, Cathay Capital announced its acquisition of Wedia, Writer closed a $200MM Series C Financing, led by Insight Venture Management and Samjo Capital
Download Now
![Diagnostics and Tools Blue Book November 2024](https://www.crosstreecapital.com/hubfs/AdobeStock_982679813.jpeg)
BlueBook
Diagnostics and Tools Blue Book November 2024
Highlights from this edition: Ambry Genetics was acquired by Tempus, TA Associates announced its acquisition of Nexus AG, Sirona Medical closed a $42MM Series A Financing, led by Greatpoint Investment, 8VC, and Avidity Partners
Download Now
/
6
Load More
Gain Insight Into The Health
Sciences Industries
Sign up to receive the the latest reports, research, BlueBooks, and more from the Crosstree team.